{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:03:48Z","timestamp":1761991428503,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jgar.2023.02.017","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T20:41:44Z","timestamp":1677876104000},"page":"31-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacokinetics of vancomycin and meropenem during continuous online hemodiafiltration: A case report"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-1598","authenticated-orcid":false,"given":"Yoko","family":"Niibe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-955X","authenticated-orcid":false,"given":"Tatsuya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-5916","authenticated-orcid":false,"given":"Shingo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-aki","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.02.017_bib0001","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1525-1594.2006.00266.x","article-title":"Online hemodiafiltration","volume":"30","author":"Van Laecke","year":"2006","journal-title":"Artif Organs"},{"key":"10.1016\/j.jgar.2023.02.017_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802639","article-title":"Intensity of renal support in critically ill patients with acute kidney injury","volume":"359","author":"Palevsky","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2023.02.017_bib0003","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","article-title":"Intensity of continuous renal-replacement therapy in critically ill patients","volume":"361","author":"Bellomo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2023.02.017_bib0004","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","article-title":"High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial","volume":"39","author":"Joannes-Boyau","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2023.02.017_bib0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.ajkd.2016.02.049","article-title":"High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial","volume":"68","author":"Park","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jgar.2023.02.017_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ckj\/sfs166","article-title":"Use of high-volume haemodiafiltration in patients with refractory septic shock and acute kidney injury","volume":"6","author":"Bourquin","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jgar.2023.02.017_bib0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/aor.13368","article-title":"Vancomycin hemodialysis: clearance differences between high-flux hemodialysis and on-line hemodiafiltration","volume":"43","author":"Rodr\u00edguez","year":"2019","journal-title":"Artif Organs"},{"key":"10.1016\/j.jgar.2023.02.017_bib0008","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ckj\/sfx009","article-title":"Optimization of anti-infective dosing regimens during online haemodiafiltration","volume":"10","author":"Jager","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jgar.2023.02.017_bib0009","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jgar.2023.02.017_bib0010","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","article-title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jgar.2023.02.017_bib0011","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/FTD.0000000000000741","article-title":"Population pharmacokinetic analysis of meropenem in critically ill patients with acute kidney injury treated with continuous hemodiafiltration","volume":"42","author":"Niibe","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jgar.2023.02.017_bib0012","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jgar.2023.02.017_bib0013","article-title":"Abdi Pour A. Drug dosing considerations in critically ill patients receiving continuous renal replacement therapy","volume":"8","author":"Jang","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.jgar.2023.02.017_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00583-19","article-title":"A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy","volume":"63","author":"Pistolesi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2023.02.017_bib0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jiac.2017.09.005","article-title":"Dosing optimization of meropenem based on a pharmacokinetic analysis in patients receiving hemodiafiltration and an in vitro model","volume":"24","author":"Yokoyama","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2023.02.017_bib0016","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.017_bib0017","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:00:54Z","timestamp":1761991254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":17,"alternative-id":["S2213716523000346"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.017","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of vancomycin and meropenem during continuous online hemodiafiltration: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}